VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 424 filers reported holding VANECK VECTORS ETF TR in Q4 2018. The put-call ratio across all filers is 1.45 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $5,082,000 | -19.2% | 185,593 | +13.1% | 0.90% | -2.0% |
| Q1 2022 | $6,292,000 | +22.1% | 164,081 | +2.0% | 0.92% | +41.8% |
| Q4 2021 | $5,154,000 | -30.0% | 160,926 | -35.6% | 0.65% | -37.7% |
| Q3 2021 | $7,360,000 | -12.2% | 249,736 | +1.2% | 1.04% | -16.5% |
| Q2 2021 | $8,385,000 | +11.0% | 246,761 | +6.1% | 1.24% | -9.1% |
| Q1 2021 | $7,556,000 | +545.8% | 232,490 | +615.6% | 1.37% | +467.2% |
| Q4 2020 | $1,170,000 | -26.5% | 32,489 | -20.1% | 0.24% | -38.0% |
| Q3 2020 | $1,591,000 | +67.5% | 40,640 | +56.9% | 0.39% | +47.9% |
| Q2 2020 | $950,000 | +1238.0% | 25,902 | +672.0% | 0.26% | +673.5% |
| Q4 2018 | $71,000 | – | 3,355 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |